Dark Horse Consulting Expands Asia with CJ PARTNERS Deal
Walnut Creek, California & Tokyo, Japan, April 21, 2026 In a strategic move to strengthen its global consulting footprint...
Alzheimer’s Disease ASCO 2026 Autoimmune Disease Bio-Pharma biologics biopharma biopharma innovation Biotechnology Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development FDA fda approval FDA clearance GCP Gene Therapy Healthcare Innovation Immuno-Oncology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody NSCLC Oncology oncology innovation oncology research Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 trial Precision Medicine Precision Oncology rare disease rare diseases Regenerative Medicine regulatory compliance targeted therapy
Walnut Creek, California & Tokyo, Japan, April 21, 2026 In a strategic move to strengthen its global consulting footprint...
Ottawa, Canada — February 6, 2026 Health authorities have issued a public advisory announcing the recall of two lots...
